Senator Braun (R-IN) Introduces Legislation to Authorize HHS to Audit 340B Income
On September 23, U.S. Senator Mike Braun (R-IN) introduced a bill to amend the 340B statute to allow HHS to audit 340B covered entities to determine how they use “net…
HRSA Refers Six Pharmaceutical Manufacturers to HHS-Office of the Inspector General for Imposition of Civil Monetary Penalties
Earlier today, HRSA sent letters to Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics alerting them that the agency has notified the HHS-Office of the Inspector General (OIG),…
Gilead Notifies Pharmacies of Its New PAP/MAP Policy
Gilead recently notified pharmacies that beginning January 1, 2022, they must enter into a participation agreement in order to submit claims and receive reimbursement under Gilead’s Patient Assistance Program and…